期刊文献+

EB病毒逃避宿主免疫的机制 被引量:5

Study on the Mechanism of EB Virus in Evading the Host Immune
下载PDF
导出
摘要 EB病毒(EBV)在感染宿主的过程中需要克服宿主免疫系统的防御,因此衍生了一系列干扰人体免疫的策略。EBV感染后会长期潜伏在宿主B细胞中,并对宿主主要组织相容性复合体分子的表达进行干扰,影响宿主的抗病毒免疫。EBV表达的BCRF1蛋白可刺激Th2细胞的产生,BARF1蛋白可诱发α型干扰素等细胞因子的分泌,多种病毒蛋白均可干扰细胞因子网络。同时EBV编码的BHRF1等蛋白可发挥抗凋亡作用。该文就EBV免疫逃避的最新研究进展进行了归纳总结,以期为EBV防控、新型疫苗设计等提供参考。 In order to resist the defense from the host immune system in the infection process,EB virus( EBV) has to produce a series of interference strategies against human immune system. EBV can latent in the B cells of host for a long term after infection and interfere the expression of host MHC to affect the host immune system. EBV BCRF1 protein can induce the creation of Th2 cells,and BARF1 protein can induce the secretion of interferon-α. Many viral proteins could interfere in the cytokine network. Besides,BHRF1 protein encoded by EBV may play an anti-apoptotic role in the host body. Here is to make a review of latest research progress on the mechanisms of EBV in evading the host immune in order to provide reference for EBV prevention and control as well as the design of new vaccines.
出处 《医学综述》 2015年第3期417-420,共4页 Medical Recapitulate
关键词 EB病毒 免疫逃逸 宿主免疫 Epstein-Barr virus Immune escape Host immune
  • 相关文献

参考文献35

  • 1Mossad SB,Macknin ML,Medendorp SV,et al.Zinc gluconate lozenges for treating the common cold.A randomized,double-blind,placebo-controlled study[J].Ann Intern Med,1996,125(2):81-88.
  • 2Morizono K,Chen IS.Receptors and tropisms of envelope viruses[J].Curr Opin Virol,2011,1(1):13-18.
  • 3Martin HJ,Lee JM,Walls D,et al.Manipulation of the toll-like receptor 7 signaling pathway by Epstein-Barr virus[J].J Virol,2007,81(18):9748-9758.
  • 4Frappier L.Contributions of Epstein-Barr nuclear antigen 1(EBNA1)to cell immortalization and survival[J].Viruses,2012,4(9):1537-1547.
  • 5Wycisk AI,Lin J,Loch S,et al.Epstein-Barr viral BNLF2a protein hijacks the tail-anchored protein insertion machinery to block antigen processing by the transport complex TAP[J].J Biol Chem,2011,286(48):41402-41412.
  • 6Rowe M,Glaunsinger B,van Leeuwen D,et al.Host shutoff during productive Epstein-Barr virus infection is mediated by BGLF5 and may contribute to immune evasion[J].Proc Natl Acad Sci U S A,2007,104(9):3366-3371.
  • 7Zuo J,Currin A,Griffin BD,et al.The Epstein-Barr virus G-protein-coupled receptor contributes to immune evasion by targeting MHC classⅠmolecules for degradation[J].PLo S Pathog,2009,5(1):e1000255.
  • 8Croft NP, Shannon-Lowe C, Bell AI, et al. Stage-specific inhibition of MHC classlpresentation by the Epstein-Ban' virus BNI22a pro- tein during virus lytic cycle[ J ]. PLoS Pathog,2009,5(6) :e1000490.
  • 9Yoon SI,Jones BC,Logsdon NJ,et al.Epstein-Barr virus IL-10engages IL-10R1 by a two-step mechanism leading to altered signaling properties[J].J Biol Chem,2012,287(32):26586-26595.
  • 10Jochum S,Moosmann A,Lang S,et al.The EBV immunoevasins v IL-10 and BNLF2a protect newly infected B cells from immune recognition and elimination[J].PLo S Pathog,2012,8(5):e1002704.

同被引文献84

  • 1邓先军,邓德英,秦镜.传染性单核细胞增多症的中医证治[J].河南中医药学刊,1995,10(3):33-34. 被引量:4
  • 2Jha H C,Mehta D,Lu J,et al.Gammaherpesvirus Infection of Human Neuronal Cclls[J].mBio,2015,6(6):e01844-15.
  • 3Cohen J I.Epstein-Barr virus infection[J]. N Engl J Meal,2000,343(7):481-492.
  • 4Vockerodt M,Yap L F,Shannon-Lowe C,et al.The Epstein Barr virus and the pathogenesis of lymphoma[J].The Journal of pathology,2015,235(2): 312-322.
  • 5White R E,R/imer P C,Naresh K N,et al.EBNA3B-deficient EBV promotes B cell lymphomagenesis in humanized mice and is found in human tumors[J].The Journal of clinical investigati on,2012,122(4): 1487-1502.
  • 6Fujiwaru S,Takei M.Epstein - Barr virus and autoimmune diseases[J]. Clinical and Experimental Neuroimmunology,2015,6(S1):38-48.
  • 7Vereide D T,Seto E,Chiu Y F,et al.Epstein Barr virus maintains lymphomas via its miRNAs[J].Oncogene,2014,33(10):1258-1264.
  • 8Taylor G S,Long H M,Brooks J M,et al.The immunology of Epstein-Barr virus-induced disease[J].Arnua| review of immunology,2015,33:787-821.
  • 9Khan G,Hashim M J.Global burden of deaths from Epstein-Barr virus attributable malignancies 1990-2010[J].Infectious agents and cancer,2014,9(1):1- 11.
  • 10Khedmat H,Karbasi-Afshar R,Agah S,et al.A meta-analysis of potential relationship between Epstein-Barr-Encoded-RNA (EBER) and onset time of post-transplant lymphoproliferative disorders[J].Saudi Journal of Kidney Diseases and Transplantation,2015,26(2):232-237.

引证文献5

二级引证文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部